Need help? Our team of experienced experts is here for you with full support.
AKA-416
AktiAmino™ Fmoc-Gly-His(Trt)-OH
Cat. No.
AKA-416
CAS No.
950186-07-9
MF
C42H36N4O5
MW
676.76
AktiAmino™ Fmoc-Gly-His(Trt)-OH is a doubly protected Gly-L-His dipeptide derivative with an Fmoc-protected N-terminal amino group, a Trt-protected histidine imidazole nitrogen, and a free C-terminal carboxyl group. It serves as a dipeptide building block for solid-phase peptide synthesis.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Storage and Shipping
References
Product Name
AktiAmino™ Fmoc-Gly-His(Trt)-OH
CAS No.
950186-07-9
MF
C42H36N4O5
MW
676.76
Specification
99%
Documents
Certificate of Analysis (COA), Specification sheet, Safety Data Sheet (SDS/MSDS) etc.
Description
AktiAmino™ Fmoc-Gly-His(Trt)-OH is a doubly protected Gly-L-His dipeptide derivative with an Fmoc-protected N-terminal amino group, a Trt-protected histidine imidazole nitrogen, and a free C-terminal carboxyl group. It serves as a dipeptide building block for solid-phase peptide synthesis. Packing: 1kg/bag,25kg/drum or as request Availability: In stock
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1].Novel lipid-tripeptide based hydrogel-forming agent and hydrogel. European patent application EP2180027A1. 2010.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.